Literature DB >> 18587606

Ectopic atrial rhythm is a preablation predictor of atrioventricular nodal reentrant tachycardia in children.

Christina Y Miyake1, Frank Cecchin, Edward P Walsh, Charles I Berul.   

Abstract

BACKGROUND: Supraventricular tachycardia (SVT) is a common tachyarrhythmia among pediatric patients. Usually, non-preexcited SVT is attributable to either atrioventricular nodal reentry tachycardia (AVNRT) or unidirectional retrograde accessory pathway (URAP), but these cannot be differentiated on a baseline electrocardiogram (ECG). The ability to identify the SVT mechanism in children may guide decision-making about treatment and counseling regarding electrophysiology study (EPS). Clinical experience suggested that ectopic atrial rhythm (EAR) is more frequently observed on preablation ECGs of pediatric patients with AVNRT. This study aimed to determine whether EAR is predictive of AVNRT.
METHODS: A 10-year single-center retrospective review was conducted with patients who underwent ablation for SVT from 1997 through 2006. All pediatric patients with documented AVNRT or URAP during EPS were included. The exclusion criteria specified prior ablation, Wolff-Parkinson-White syndrome, or complex congenital heart disease. A patient was considered to have EAR if a preablation ECG had a p-wave axis less than 0 degrees or greater than 90 degrees or a wandering atrial pacemaker with at least three different p-wave morphologies.
RESULTS: The review found 457 eligible patients ages 0.5 to 21 years: 285 with AVNRT and 172 with URAP. Patients with congenital heart defects represented 5.6% of the AVNRT group and 2.9% of the URAP group. Ectopic atrial rhythm was seen in 45 (16%) of 285 patients with AVNRT compared with 10 (6%) of 172 URAP patients (p = 0.001). The sensitivity and specificity of EAR for AVNRT was 16% and 94%, respectively, and the positive predictive value was 82%. There was no difference in heart rate or QRS duration between the two groups.
CONCLUSION: On preablation ECG for pediatric SVT patients, EAR is a reasonably specific marker for AVNRT.

Entities:  

Mesh:

Year:  2008        PMID: 18587606     DOI: 10.1007/s00246-008-9255-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  7 in total

1.  Pacemaker shift in the rabbit sinoatrial node in response to vagal nerve stimulation.

Authors:  N Shibata; S Inada; K Mitsui; H Honjo; M Yamamoto; R Niwa; M R Boyett; I Kodama
Journal:  Exp Physiol       Date:  2001-03       Impact factor: 2.969

2.  Electrophysiologic properties of the atrioventricular node in pediatric patients.

Authors:  M I Cohen; T S Wieand; L A Rhodes; V L Vetter
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

3.  Inaccuracy of Wolff-Parkinson-white accessory pathway localization algorithms in children and patients with congenital heart defects.

Authors:  Yaniv Bar-Cohen; Paul Khairy; James Morwood; Mark E Alexander; Frank Cecchin; Charles I Berul
Journal:  J Cardiovasc Electrophysiol       Date:  2006-07

4.  Characterizing dual atrioventricular nodal physiology in pediatric patients with atrioventricular nodal reentrant tachycardia.

Authors:  Dominic J Blurton; Anne M Dubin; Nancy A Chiesa; George F Van Hare; Kathryn K Collins
Journal:  J Cardiovasc Electrophysiol       Date:  2006-06

Review 5.  Ventricular arrhythmias: when to worry.

Authors:  M E Alexander; C I Berul
Journal:  Pediatr Cardiol       Date:  2000 Nov-Dec       Impact factor: 1.655

6.  Electrocardiographic differentiation of typical atrioventricular node reentrant tachycardia from atrioventricular reciprocating tachycardia mediated by concealed accessory pathway in children.

Authors:  Edgar T Jaeggi; Thomas Gilljam; Urs Bauersfeld; Christine Chiu; Robert Gow
Journal:  Am J Cardiol       Date:  2003-05-01       Impact factor: 2.778

7.  Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways.

Authors:  Chuen-Wang Chiou; Shih-Ann Chen; Ming-Ho Kung; Mau-Song Chang; Eric N Prystowsky
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.